Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Fructose phosphotransferase system (Fru-PTS) is a complex bacterial transport system that facilitates the simultaneous translocation and phosphorylation of fructose across the cytoplasmic membrane. It functions as part of the larger phosphoenolpyruvate (PEP)-dependent sugar phosphotransferase system, utilizing PEP as a high-energy phosphate donor to convert fructose into fructose-1-phosphate during transport (UniProt, 2023). This system typically consists of general components like Enzyme I and HPr, alongside the fructose-specific Enzyme II (EII) complex, which provides the substrate specificity (PubMed, PMID: 15659676). Beyond its role in nutrient acquisition, the Fru-PTS is a critical regulator of bacterial physiology, influencing carbon catabolite repression and the expression of virulence factors in various pathogens (Microbiology Spectrum, 2015). Because the PTS is unique to bacteria and absent in humans, it is considered a promising target for the development of narrow-spectrum antimicrobial agents (PubMed, PMID: 22493367). Inhibiting this system can impair bacterial growth and reduce the fitness of pathogens like Streptococcus mutans in the oral cavity or enteric pathogens in the gut (Journal of Bacteriology, 2010). Current therapeutic strategies involve the use of PEP analogs or small molecules that disrupt the phosphorelay or the transport channel itself.
Inhibition of the phosphoenolpyruvate-dependent transport and phosphorylation of fructose, disrupting bacterial energy metabolism and signal transduction.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fructose phosphotransferase system (Fru-PTS).